Rosacea – Global Market Growth, Trends and Forecasts 2019-2024: Leading Players are Bausch Health Companies, Nestle (Galderma), Leo Pharma, Hovione FarmaCiencia, and Aclaris Therapeutics –

DUBLIN–(BUSINESS WIRE)–May 9, 2019–The “Rosacea Market – Growth, Trends, and Forecast (2019 – 2024)” report has been added to’s offering.

With rising incidence, the awareness among the physicians and societies has also increased, which further drives the demand of this market. However, the presence of generic drugs to curb the related symptoms hinders the growth of the rosacea market.

Key Market Trends

Antibiotics is Estimated to Hold the Largest Share During the Forecast Period

For over 60 years, antibiotics have been prescribed as a treatment for the symptoms of rosacea. It can reduce the number of acne pimples and bacterial inflammation or redness around the acne pimples. Antibiotics are available in two forms, including oral antibiotics and topical antibiotics.

Oral antibiotics, such as tetracycline, doxycycline, and minocycline, have been proven to control rosacea’s bacterial component and also has inflammatory benefits. It is most commonly preferred by physicians and doctors for early relief from the disease, but are usually for a long period, which drives the sales of this segment over other sub segments. So, the high usage of antibiotics for the treatment of rosacea is the main factor for the growth of the market.

However, there are certain side effects associated with the usage of antibiotics, including bloating, loss of appetite, abdominal pain, and many others, which are restraining their adoption as a treatment.

North America is Expected to Maintain the Largest Share in the Rosacea Market

North America has multiple factors, which support the growth of this market, better than other geographic regions. Some factors include high healthcare expenditure by the government each year on pharmaceuticals and medical devices and awareness in the society (several societies organizing campaigns across the US and Canada).

As per the estimates of the National Rosacea Society (NRS), about 16 million Americans suffer from rosacea and maybe millions more in temporary remission. The companies also prefer to release their products first in the United States, due to favorable regulatory requirements, which drives the demand for this market

Competitive Landscape

The rosacea market has observed growing competition among leading players, majorly across the developed markets. Some of the major market players include Bausch Health Companies, Nestle (Galderma), Leo Pharma, Hovione FarmaCiencia, and Aclaris Therapeutics, among others.

Key Topics Covered


1.1 Study Deliverables

1.2 Study Assumptions

1.3 Scope of the Study




4.1 Market Overview

4.2 Market Drivers

4.2.1 Increasing Incidence & Prevalence of Rosacea

4.2.2 Increasing Inclination Toward Combination Products

4.3 Market Restraints

4.3.1 Increased Use of Generic Drugs

4.4 Porter’s Five Forces Analysis


5.1 By Drug Class

5.1.1 Antibiotics

5.1.2 Alpha Agonists

5.1.3 Retinoid

5.1.4 Corticosteroids

5.1.5 Immunosuppressants

5.1.6 Other Drug Classes

5.2 By Mode of Administration

5.2.1 Topical

5.2.2 Oral5.3 Geography5.3.1 North America5.3.2 Europe5.3.3 Asia-Pacific5.3.4 Middle East & Africa5.3.5 South America6 COMPETITIVE LANDSCAPE6.1 Company Profiles6.1.1 Aclaris Therapeutics6.1.2 Amorepacific Corporation6.1.3 Bausch Health Companies Inc.6.1.4 Foamix Pharmaceuticals6.1.5 Hovione FarmaCiencia S.A.6.1.6 Leo Pharma Inc.6.1.7 Nestle7 MARKET OPPORTUNITIES AND FUTURE TRENDSFor more information about this report visit View source version on CONTACT: ResearchAndMarkets.comLaura Wood, Senior Press Managerpress@researchandmarkets.comFor E.S.T Office Hours Call 1-917-300-0470For U.S./CAN Toll Free Call 1-800-526-8630For GMT Office Hours Call +353-1-416-8900Related Topics:DermatologyKEYWORD:INDUSTRY KEYWORD: HEALTH GENERAL HEALTHSOURCE: Research and MarketsCopyright Business Wire 2019.PUB: 05/09/2019 01:07 PM/DISC: 05/09/2019 01:07 PM


Click Here to Continue...